These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8072739)

  • 21. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-iodobenzylguanidine derivatives containing a second guanidine moiety.
    Vaidyanathan G; Shankar S; Affleck DJ; Alston K; Norman J; Welsh P; LeGrand H; Zalutsky MR
    Bioorg Med Chem; 2004 Apr; 12(7):1649-56. PubMed ID: 15028258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue.
    Vaidyanathan G; Affleck DJ; Zalutsky MR
    Appl Radiat Isot; 2005 Mar; 62(3):435-40. PubMed ID: 15607920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and efficacy of 131I-meta-iodobenzylguanidine in two neuroblastoma xenografts.
    Gaze MN; Hamilton TG; Mairs RJ
    Br J Radiol; 1994 Jun; 67(798):573-8. PubMed ID: 8032811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.
    Barrett JA; Joyal JL; Hillier SM; Maresca KP; Femia FJ; Kronauge JF; Boyd M; Mairs RJ; Babich JW
    Cancer Biother Radiopharm; 2010 Jun; 25(3):299-308. PubMed ID: 20578835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Vaidyanathan G; Zhao XG; Strickland DK; Zalutsky MR
    J Nucl Med; 1997 Feb; 38(2):330-4. PubMed ID: 9025764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of meta-iodobenzylguanidine uptake in neuroblastoma cells by elevated temperature.
    Armour A; Mairs RJ; Gaze MN; Wheldon TE
    Br J Cancer; 1994 Sep; 70(3):445-8. PubMed ID: 8080728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosynthesis of no-carrier-added
    Green M; Lowe J; Kadirvel M; McMahon A; Westwood N; Chua S; Brown G
    J Radioanal Nucl Chem; 2017; 311(1):727-732. PubMed ID: 28111488
    [No Abstract]   [Full Text] [Related]  

  • 29. No-carrier-added meta-[123I]iodobenzylguanidine: synthesis and preliminary evaluation.
    Vaidyanathan G; Zalutsky MR
    Nucl Med Biol; 1995 Jan; 22(1):61-4. PubMed ID: 7735171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, radiolabelling and stability of radioiodinated m-iodobenzylguanidine, a review.
    Wafelman AR; Konings MC; Hoefnagel CA; Maes RA; Beijnen JH
    Appl Radiat Isot; 1994 Oct; 45(10):997-107. PubMed ID: 7994289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of radioiodination of meta-iodobenzylguanidine (MIBG) catalysed by in situ generated Cu(I) and directly added Cu(II).
    Prabhakar G; Mehra KS; Ramamoorthy N; Chattopadhyay S; Oommen R; Narasimhan S; Nair NA; Gunasekaran S
    Appl Radiat Isot; 1999 Jun; 50(6):1011-4. PubMed ID: 10355103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodine-131 meta-iodobenzylguanidine (131I-MIBG) for the localization of suspected phaeochromocytoma.
    Warren MJ; Shepstone BJ; Soper N
    Nucl Med Commun; 1989 Jul; 10(7):467-75. PubMed ID: 2797626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification by nifedipine of 131I-meta-iodobenzylguanidine kinetics in malignant phaeochromocytoma.
    Blake GM; Lewington VJ; Fleming JS; Zivanovic MA; Ackery DM
    Eur J Nucl Med; 1988; 14(7-8):345-8. PubMed ID: 3181183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment planning for 131I-mIBG radiotherapy of neural crest tumours using 124I-mIBG positron emission tomography.
    Ott RJ; Tait D; Flower MA; Babich JW; Lambrecht RM
    Br J Radiol; 1992 Sep; 65(777):787-91. PubMed ID: 1393416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    Macfarlane D; Gonin J; Wieland D; Mangner T; Froelich J; Beierwaltes W; Shapiro B
    Eur J Nucl Med; 1996 Feb; 23(2):131-40. PubMed ID: 8925846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 131I-MIBG scintigraphy in neural crest tumours.
    Samuel AM; Murugesan S; Kurkure PA; Advani SH; Sonawane GA; Noronha OP
    Indian J Cancer; 1994 Jun; 31(2):103-10. PubMed ID: 7927441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Scintigraphy with radioiodinated meta-iodobenzylguanidine in the diagnosis of neuroblastoma].
    Müller-Gärtner HW; Erttmann R; Helmke K
    Nuklearmedizin; 1985 Dec; 24(5-6):222-6. PubMed ID: 3912731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uptake of the neuron-blocking agent meta-iodobenzylguanidine and serotonin by human platelets and neuro-adrenergic tumour cells.
    Rutgers M; Tytgat GA; Verwijs-Janssen M; Buitenhuis C; Voûte PA; Smets LA
    Int J Cancer; 1993 May; 54(2):290-5. PubMed ID: 8486431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.